Our Services

Accelerating science from Lab to Market

Strategic solutions for every stage of your preclinical development. We guide biotechnology companies, SMEs, and research centers through complex regulatory environments with excellence and precision.

Scientific research in laboratory

Driving your scientific advancement

What drives our acceleration

We provide comprehensive consulting services across the full spectrum of preclinical development

Strategic Acceleration

We reduce the time between discovery and real-world application, optimizing every preclinical phase with strategies that drive the transition from laboratory to market.

Regulatory Rigor

We guide biotechnology companies, SMEs, and research centers through complex regulatory environments, transforming each requirement into strategic opportunities that enable you to reach accelerated market approvals.

Science–Industry Bridge

We unite research, clinical strategy, and market vision, acting as the bridge that converts potential new life-saving therapies into safe, differentiated, high-impact solutions.

Vision and Precision

We provide clarity and confidence at every step: expert analysis, precise planning, and a global perspective that ensure confident decisions and results with excellence.

Comprehensive Preclinical Services

From initial concept to regulatory submission, we provide end-to-end support for your preclinical development needs.

Preclinical Development

Comprehensive design and execution of preclinical studies, from initial concept through regulatory submission.

Regulatory Strategy

Expert guidance through FDA, EMA, and international regulatory pathways, ensuring compliance at every stage.

GLP Compliance

Support for Good Laboratory Practice certifications and quality assurance systems that meet global standards.

Study Design & Protocol Development

Scientifically rigorous study designs that address regulatory requirements and advance your development goals.

Specialized Expertise

Our team brings deep expertise across therapeutic areas and cutting-edge technologies.

Large & Small molecule drug development (including RNA-based vaccines)

Immunotherapy & Oncology

Alternative Methods (NAMs)

Toxicological Risk Assessments (TRAs)

Due diligence evaluations

International Collaboration

Digital Monitoring & Automation (Preclinical and CMC)

Ready to accelerate your preclinical development?

Contact us today to discuss how we can support your project from laboratory to market.